Healthy Skepticism Library item: 3509
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
MaLAM letter follow up—Janssen
MaLAM Newsletter 1987 Jun; 1-2
Abstract:
Janssen acknowledges that some of its promotional literature does not meet the standards set by the IFPMA Code but continues to claim that loperamide is useful in treating diarrhea.
Keywords:
*analysis/developing countries/loperamide/Janssen/diarrhea/company responses/quality of information/IFPMA/ International Federation of Pharmaceutical Manufacturers Associations/ Code of Pharmaceutical Marketing Practices (IFPMA)/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: DIARRHEA/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES